Skip to main content

Table 2 Provision of evidence-based smoking cessation treatment by healthcare system and provider characteristics

From: Evidence-based smoking cessation treatment: a comparison by healthcare system

Exposure

Provided Evidence-Based Smoking Cessation Treatment

N = 328 (%)a

Did not Provide Evidence-Based Smoking Cessation Treatment

N = 38 (%)b

Adjusted OR (95% CI) of Providing Evidence-Based Smoking Cessation Treatment c

Primary Analysis: Healthcare System

 Veterans Health Administration

90 (27.4%)

3 (7.9%)

4.3 (1.3–14.4)

 Academic Health Center

238 (72.6%)

35 (92.1%)

Refd

Secondary Analysis: Healthcare Provider Baseline Characteristics

 Sociodemographic Characteristics

  Gender, n (%)

   Female

182 (55.5%)

24 (63.2%)

0.7 (0.4–1.5)

  Ethnicity/Race, n (%)c

   White

261 (79.6%)

36 (94.7%)

0.2 (0.1–1.0)

   Non-White

67 (20.4%)

2 (5.3%)

Ref

 Professional Characteristics

  Medical Specialty, n (%)

   General Internal Medicine

199 (60.7%)

16 (42.1%)

1.4 (0.4–4.4)

   Hematology/Oncology

57 (17.4%)

12 (31.6%)

0.5 (0.2–1.8)

   Pulmonology

35 (10.7%)

4 (10.5%)

Ref

   Gynecology

37 (11.3%)

6 (15.8%)

0.9 (0.2–3.5)

  Medical Position, n (%)

   Attending

156 (47.6%)

15 (39.5%)

Ref

   Non-Attending

172 (52.4%)

23 (60.5%)

0.7 (0.4–1.5)

  Years Since Completion of Terminal Degree, n (%)

    < 1–5

155 (47.3%)

20 (52.6%)

Ref

   6–15

91 (27.7%)

10 (26.3%)

1.1 (0.5–2.5)

    > 16

80 (24.4%)

8 (21.1%)

1.1 (0.4–2.6)

   Missing

2 (0.6%)

0

 

  Practice Location, n (%)

   Hospital-based clinic

240 (73.2%)

22 (57.9%)

2.3 (1.1–4.7)

   Community-based clinic

88 (26.8%)

16 (42.1%)

Ref

  <  50% of Time Providing Direct Patient Care, n (%)

79 (24.1%)

8 (21.1%)

1.1 (0.5–2.6)

  Perceived Percentage of Current Smokers in Healthcare Provider’s Practice, median (IQR)

25 (15, 40)

20 (10, 25)

1.3 (1.0–2.7)

  Perceived Percentage of Former Smokers in Healthcare Provider’s Practice, median (IQR)

30 (20, 50)

35 (20, 50)

0.9 (0.8–2.7)

  Perceived Effectiveness of Smoking Cessation at Decreasing Cancer Mortality, n (%)

   Very Effective

234 (71.3%)

26 (68.4%)

1.1 (0.5–2.3)

   Not Very Effective

92 (28.0%)

12 (31.6%)

Ref

   Missing

2 (0.6%)

0

 
  1. aEvidence-based smoking cessation treatment defined as providing counseling and FDA-approved smoking cessation medications or placing a referral for smoking cessation services within the past 12 months. bNon-evidence-based smoking cessation treatment defined as not providing counseling and FDA-approved smoking cessation medications or placing a referral for smoking cessation services within the past 12 months. cFor the primary analysis, logistic regression (adjusted by medical specialty) was used to assess the association of healthcare system with the odds of providing evidence-based smoking cessation treatment; for the secondary analysis logistic regression (adjusted for healthcare system) was used to assess the association of healthcare provider characteristics with the odds of providing evidence-based smoking cessation treatment; Missing values were not included in the models. dRef refers to reference
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us